Literature DB >> 15051379

Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells.

Ratna B Ray1, Arnab Basu, Robert Steele, Aster Beyene, Jane McHowat, Keith Meyer, Asish K Ghosh, Ranjit Ray.   

Abstract

Ebola virus glycoprotein (EGP) has been implicated for the induction of cytotoxicity and injury in vascular cells. On the other hand, EGP has also been suggested to induce massive cell rounding and detachment from the plastic surface by downregulating cell adhesion molecules without causing cytotoxicity. In this study, we have examined the cytotoxic role of EGP in primary endothelial cells by transduction with a replication-deficient recombinant adenovirus expressing EGP (Ad-EGP). Primary human cardiac microvascular endothelial cells (HCMECs) transduced with Ad-EGP displayed loss of cell adhesion from the plastic surface followed by cell death. Transfer of conditioned medium from EGP-transduced HCMEC into naive cells did not induce loss of adhesion or cell death, suggesting that EGP needs to be expressed intracellularly to exert its cytotoxic effect. Subsequent studies suggested that HCMEC death occurred through apoptosis. Results from this study shed light on the EGP-induced anoikis in primary human cardiac endothelial cells, which may have significant pathological consequences.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051379     DOI: 10.1016/j.virol.2003.12.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Identification of a small-molecule entry inhibitor for filoviruses.

Authors:  Arnab Basu; Bing Li; Debra M Mills; Rekha G Panchal; Steven C Cardinale; Michelle M Butler; Norton P Peet; Helena Majgier-Baranowska; John D Williams; Ishan Patel; Donald T Moir; Sina Bavari; Ranjit Ray; Michael R Farzan; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens.

Authors:  Lan Wu; Wing-Pui Kong; Gary J Nabel
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex.

Authors:  Frédéric Dallaire; Paola Blanchette; Peter Groitl; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 4.  Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.

Authors:  Ilhem Messaoudi; Gaya K Amarasinghe; Christopher F Basler
Journal:  Nat Rev Microbiol       Date:  2015-10-06       Impact factor: 60.633

5.  Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

Authors:  Osvaldo Martinez; Charalampos Valmas; Christopher F Basler
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

Review 6.  Filovirus Strategies to Escape Antiviral Responses.

Authors:  Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

7.  Novel Small Molecule Entry Inhibitors of Ebola Virus.

Authors:  Arnab Basu; Debra M Mills; Daniel Mitchell; Esther Ndungo; John D Williams; Andrew S Herbert; John M Dye; Donald T Moir; Kartik Chandran; Jean L Patterson; Lijun Rong; Terry L Bowlin
Journal:  J Infect Dis       Date:  2015-07-22       Impact factor: 5.226

Review 8.  Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity.

Authors:  Amanda N Pinski; Ilhem Messaoudi
Journal:  Curr Opin Virol       Date:  2021-11-05       Impact factor: 7.090

9.  Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein.

Authors:  Joseph R Francica; Meghan K Matukonis; Paul Bates
Journal:  Virology       Date:  2008-11-14       Impact factor: 3.616

10.  The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.

Authors:  Allison Groseth; Andrea Marzi; Thomas Hoenen; Astrid Herwig; Don Gardner; Stephan Becker; Hideki Ebihara; Heinz Feldmann
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.